Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02852577Phase 4Completed
Phase 4, randomised, open-label trial in panic disorder comparing Clonazepam with Paroxetine (2 arms). Primary endpoint: Clinical Global Impression - Severity at 8 weeks. Started Jan 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02852577.